Frontlight ResearchEarly access
Trial site
The Lundquist Institute at Harbor UCLA Medical Center
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)2 trials
- Rheumatoid arthritis1 trial
- Stroke1 trial
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center2 trials
- DiaMedica Therapeutics Inc1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
Running trials
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Recruiting
Active, not recruiting
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026